These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 22616127)

  • 1. [A survey of compliance to oral anti-cancer drugs in outpatients].
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):485-8. PubMed ID: 22616127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current problems for outpatients undergoing cancer chemotherapy in Ehime Priority Hospitals of Cancer Care Network (Ehime Cancer Kyoten Hospitals)].
    Morita J; Yakushijin Y; Kojima Y; Tsuneoka K; Fujiwara M; Mori H; Yamashita H; Yamaguchi I; Fujita T; Yano T; Matsuhisa T; Okada K; Shiraishi T; Hara M; Matsuno T; Tanimizu M
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):599-605. PubMed ID: 21498988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenges of oral agents as antineoplastic treatments.
    Given BA; Spoelstra SL; Grant M
    Semin Oncol Nurs; 2011 May; 27(2):93-103. PubMed ID: 21514479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of health-related quality of life in cancer outpatients treated with chemotherapy].
    Yokoyama T; Kurokawa Y; Kani R; Takatori E; Nokiguchi S; Suzuki Y; Kawashima H; Uenishi M; Kawashima M; Osato Y; Miyamatsu H; Sofuni A; Itoi T; Ikeda N; Ohyashiki K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):409-14. PubMed ID: 22421769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term oral administration of anticancer drug (author's transl)].
    Soejima S
    Nihon Gan Chiryo Gakkai Shi; 1979 Dec; 14(7):1136-45. PubMed ID: 120403
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessment and measurement of adherence to oral antineoplastic agents.
    Spoelstra SL; Given CW
    Semin Oncol Nurs; 2011 May; 27(2):116-32. PubMed ID: 21514481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer, drug medication and noncompliance.
    Dimitrova ZD; Petkova VB
    Boll Chim Farm; 2000; 139(3):146-8. PubMed ID: 10961026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient cancer drug costs: changes, drivers, and the future.
    Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW
    Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of totally implantable venous system in cancer patients. Surgical technique and initial clinical experience].
    Ferranti F; Chichi GL; Mazzola L; Triveri P; Palmieri RM
    G Chir; 2002 May; 23(5):225-8. PubMed ID: 12228978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center.
    Chan A; Leow YC; Sim MH
    J Oncol Pharm Pract; 2009 Sep; 15(3):161-5. PubMed ID: 19171555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of psychological distress in cancer outpatients treated with chemotherapy].
    Yokoyama T; Murakoshi A; Kurokawa Y; Kani R; Hayabe H; Miyasato A; Osato Y; Miyamatsu H; Sofuni A; Itoi T; Yamada K; Ikeda N; Iimori M; Ohyashiki K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):415-9. PubMed ID: 22421770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring the side effects of cancer chemotherapy].
    Kurimoto R; Takiguchi Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():102-6. PubMed ID: 25831732
    [No Abstract]   [Full Text] [Related]  

  • 13. [The current status of nausea, vomiting and food intake in outpatients with cancer chemotherapy].
    Nishi K; Kurokawa K; Hara J; Demura Y; Fujikawa N; Nikko Y; Yoshizaki S; Yamada C
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):607-11. PubMed ID: 21498989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical hyperthermia combined with drugs and radiation. A phase I/II study.
    Dahl O; Mella O; Mehus A; Liavaag PG
    Strahlenther Onkol; 1987 Jul; 163(7):446-8. PubMed ID: 3616903
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral cancer chemotherapy: the promise and the pitfalls.
    McLeod HL; Evans WE
    Clin Cancer Res; 1999 Oct; 5(10):2669-71. PubMed ID: 10537326
    [No Abstract]   [Full Text] [Related]  

  • 16. Policy implications of oral agents.
    Spoelstra SL; Given BA; Given CW; Grant M
    Semin Oncol Nurs; 2011 May; 27(2):161-5. PubMed ID: 21514485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral agents in cancer treatment: the context for adherence.
    Barton D
    Semin Oncol Nurs; 2011 May; 27(2):104-15. PubMed ID: 21514480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
    Navarro RP; Morrow T; Baran R
    Manag Care Interface; 2002 Jul; 15(7):55-62. PubMed ID: 12143298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. U.S. survey reports oral chemotherapy practice and safety patterns.
    Becze E
    ONS Connect; 2014 Mar; 29(1):34-5. PubMed ID: 24669533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.